Additional resources online:

NPC MEMBERS
2 0 0 9 www.npcnow.org
contains a wealth of information
Abbott Laboratories
www.abbott.com about the biopharmaceutical
industry’s most pressing issues,
AstraZeneca LP
including a research and
www.astrazeneca-us.com
publications library and daily
Bayer HealthCare Pharmaceuticals news updates
pharma.bayer.com

Boehringer Ingelheim Pharmaceuticals, Inc.

www.boehringer-ingelheim.com
The National Pharmaceutical Council (NPC) is the credible and trusted voice of

ence
Bristol-Myers Squibb Company
the biopharmaceutical industry on the critical issues of evidence, the value of medicines for
www.bms.com
patients, and innovation. E.V.I.dently
Evidence. Value. Innovation

e
Daiichi Sankyo, Inc.
www.daiichisankyo-us.com

u
OUR MISSION

Evid
NPC’s monthly electronic

Val
Eisai Inc. newsletter focused on evidence-

on
www.eisai.com based medicine and related
NPC sponsors, participates in and promotes scientific analyses of the appropriate use of research relevant to the

ati
Eli Lilly and Company
www.lilly.com biopharmaceuticals, and the clinical and economic value of improved health outcomes biopharmaceutical industry
through innovation. NPC actively participates with a variety of health care stakeholders to

ov
Johnson & Johnson
www.jnj.com demonstrate and communicate the value of biopharmaceuticals and vaccines through

Inn
practical, evidence-based applications and tools.
Merck & Co., Inc.
www.merck.com
Novartis Pharmaceuticals Corporation NPC’s strategic focus is on evidence-based medicine (EBM) for health care decision making
www.novartis.com to ensure that patients have access to high quality care.
Pfizer Inc
www.pfizer.com

sanofi-aventis
www.sanofi-aventis.com

Schering-Plough Corporation
www.schering-plough.com

Takeda Pharmaceuticals
North America, Inc. 1894 Preston White Drive
www.tpna.com Reston, VA 20191-5433
Teva Neuroscience
www.tevaneuroscience.com Evidence-Based Medicine 1501 M Street, NW
Ensuring patients receive Suite 650
appropriate care based on Washington, DC 20005
individual needs and conditions
through decision making that uses Phone: 703.620.6390
the best available scientific and
Patients
1894 Preston White Drive | Reston, VA 20191-5433
Fax: 703.476.0904
www.npcnow.org clinical knowledge

www.npcnow.org

www.npcnow.org
 Additional resources online:

NPC MEMBERS
2 0 0 9 www.npcnow.org
contains a wealth of information
Abbott Laboratories
www.abbott.com about the biopharmaceutical
industry’s most pressing issues,
AstraZeneca LP
including a research and
www.astrazeneca-us.com
publications library and daily
Bayer HealthCare Pharmaceuticals news updates
pharma.bayer.com

Boehringer Ingelheim Pharmaceuticals, Inc.

www.boehringer-ingelheim.com
The National Pharmaceutical Council (NPC) is the credible and trusted voice of

ence
Bristol-Myers Squibb Company
the biopharmaceutical industry on the critical issues of evidence, the value of medicines for
www.bms.com
patients, and innovation. E.V.I.dently
Evidence. Value. Innovation

e
Daiichi Sankyo, Inc.
www.daiichisankyo-us.com

u
OUR MISSION

Evid
NPC’s monthly electronic

Val
Eisai Inc. newsletter focused on evidence-

on
www.eisai.com based medicine and related
NPC sponsors, participates in and promotes scientific analyses of the appropriate use of research relevant to the

ati
Eli Lilly and Company
www.lilly.com biopharmaceuticals, and the clinical and economic value of improved health outcomes biopharmaceutical industry
through innovation. NPC actively participates with a variety of health care stakeholders to

ov
Johnson & Johnson
www.jnj.com demonstrate and communicate the value of biopharmaceuticals and vaccines through

Inn
practical, evidence-based applications and tools.
Merck & Co., Inc.
www.merck.com
Novartis Pharmaceuticals Corporation NPC’s strategic focus is on evidence-based medicine (EBM) for health care decision making
www.novartis.com to ensure that patients have access to high quality care.
Pfizer Inc
www.pfizer.com

sanofi-aventis
www.sanofi-aventis.com

Schering-Plough Corporation
www.schering-plough.com

Takeda Pharmaceuticals
North America, Inc. 1894 Preston White Drive
www.tpna.com Reston, VA 20191-5433
Teva Neuroscience
www.tevaneuroscience.com Evidence-Based Medicine 1501 M Street, NW
Ensuring patients receive Suite 650
appropriate care based on Washington, DC 20005
individual needs and conditions
through decision making that uses Phone: 703.620.6390
the best available scientific and
Patients
1894 Preston White Drive | Reston, VA 20191-5433
Fax: 703.476.0904
www.npcnow.org clinical knowledge

www.npcnow.org

www.npcnow.org
 NPC Leadership

NPC leadership and staff bring a variety of experience from

within the biopharmaceutical industry, government health and
regulatory agencies, academia, and advocacy groups to our work.

Dan Leonard, Les D. Paul,

OUR APPROACH President, MD, MS, Vice
In shaping NPC’s research agenda and professional National Institute for Health and Clinical Excellence (NICE): variety of health care stakeholders, including patients, clinicians, leads NPC in President,
NPC is a policy research organization dedicated to the advancement of bringing the Clinical and
good evidence and science, and to fostering an environment in the United programming, we access the expertise of health outcomes How Does It Work and What Are the Implications for the U.S.?, payers and policy makers. biopharmaceu- Scientific
researchers, clinicians, market experts, and other industry The Current Evidence-Based Medicine Landscape, Principles tical industry’s Affairs, is
States that supports medical innovation. NPC educational events include:
leaders. The resulting research and educational events of Good Practice for Comparative Effectiveness Observational technical expertise and responsible for coordinating
demonstrate how the appropriate use of biopharmaceuticals Studies (GRACE), and Health Technology Assessment Town Hall Meetings – explore emerging issues of applied scientific knowledge NPC’s strategic focus
NPC focuses on research development, information dissemination, improves both patient treatment and cost outcomes in the Organizations in Other Countries and U.S. Implications. importance to the biopharmaceutical industry, such as value- to considerations of on evidence-based
based insurance design and evidence-based medicine, and evidence-based medicine, medicine (EBM) for health
education and promotion of the critical issues of evidence, innovation and overall health care environment. Value – As the United States looks for ways to ensure comparative effectiveness care decision making,
help member companies and other health care stakeholders
the value of medicines for patients. The issues we select for examination In carrying out our patient-centric mandate, NPC engages more value from medicines, NPC has undertaken several reviews, evaluation and helping to facilitate
better understand and translate research findings into everyday application. A veteran dialogue between the
and the researchers and academics we partner with position NPC as a with a targeted range of stakeholders, focusing on research studies examining this issue. The research we conduct and life; some are videotaped and made available to member association executive and biopharmaceutical industry
uniquely credible and trusted voice in the biopharmaceutical research and standards and methods for evidence generation, interpretation, commission is focused on enhancing understanding of the companies as educational tools; communications strategist and key stakeholders, and
health policy communities. and application that will improve patient outcomes while overall clinical and economic value of prescription medications with more than 20 years creating awareness and
sustaining and enhancing innovation and the value of and the contributions of those medications to improved health Corporate Roundtables – brief member companies and key of experience in strategic understanding of industry
biopharmaceuticals. and productivity among patients. Examples include recent stakeholders on industry issues, emerging trends, and related communications, legislative expertise and perspectives
NPC is working to: studies on Value-Based Insurance Design to raise awareness research; management, politics and on EBM. Dr. Paul also
For more than half a century, we have actively responded broadcast journalism, his provides clinical and
l Ensure that sound evidence is recognized by independent experts, and understanding of its value as health reform initiatives Forums/Symposiums – feature recognized health care and
to changes in the biopharmaceutical environment and previous health care industry scientific expertise for NPC’s
considered appropriately by private and public payers, reflected contributed to informative research in this arena. As we look to progress, and on Health and Productivity as a Business biopharmaceutical industry leaders; recent events include experience includes serving other research projects.
adequately in benefit designs, and incorporated into clinical practice; the future, NPC will continue to anticipate the issues, produce Strategy, which will contribute to understanding the full costs of NPC’s “Entering a New Era of Evidence,” and an NPC- as executive vice president of Dr. Paul, a Board Certified
health care for employers. sponsored symposium at ISPOR on mapping the current CER advocacy and professional pulmonologist and internist,
l Demonstrate and promote the contribution of innovative medicines to strong, evidence-based research and education, build new NPC-sponsored research publications are available online at services for America’s Health has more than 25 years of
optimizing health and wellness for patients and the entire health care partnerships, and demonstrate the benefits of new medicines Innovation – NPC believes strongly in the importance www.npcnow.org. landscape. Insurance Plans (AHIP). experience in health care.
system through scientific analyses and fact-based communications; to patients and to society. of fostering an environment that sustains and enhances NPC often works in partnership with other organizations Prior to joining NPC, his
innovation to ensure the continued discovery and Topical Educational Events – among them the Center for Medical Technology Policy Gary professional experience
l Maintain a focus on the issues related to advancing the science and Robust Research Agenda Focused on NPC’s professional programming advances the public dialogue Persinger, included senior medical
development of new medicines to improve patient health. This (CMTP), Pragmatic Approaches to Comparative Effectiveness
research aspects of the biopharmaceutical industry and preserving and Evidence, Value, Innovation by drawing on the biopharmaceutical industry’s science Vice President, affairs positions at Novartis
focus on innovation cuts across all streams of NPC-sponsored (PACE) Initiative, and the Institute for Clinical and Economic Health Services Pharmaceutical Corporation,
improving an environment supportive of innovation. NPC’s research agenda has three core areas of focus: research. One recent study, for example, focused on how base and expertise as a resource for reducing uncertainty in
Review (ICER) – to contribute strategic and scientific input on Research, AstraZeneca, and Medco
evidence, value and innovation. pharmacogenomics may impact the future costs, risks and care decisions and improving outcomes for patients. Topical coordinates Health Solutions.
critical issues such as comparative effectiveness research. And
returns on research and development, as well as incentives to educational events seek to introduce the industry’s perspective NPC’s research and
Evidence – Current efforts focus on Comparative Effectiveness NPC researchers, members, and staff also play a prominent
and expertise to inform the discussion and generate other activities related to Patricia L. Adams, Vice
Research (CER), including examining international models for invest in new research. role on professional educational programs sponsored by other
momentum around key issues. NPC’s Annual Forum, held the value of medicines President, Business
possible lessons learned as the United States continues its organizations addressing key stakeholder issues, including the and the contribution of Operations and External
each fall in Washington, DC, offers a substantive program on
exploration into the development of a CER framework. Recent U.S. Chamber of Commerce, Health Industry Forum, and the innovation to value. He Affairs, is responsible for
issues of interest to the biopharmaceutical industry and a also provides expertise on the overall operations of
NPC research in this arena includes published reports on: Translational Medicine Alliance.
research design and data NPC, including member
analysis for NPC’s research relations, external affairs,
portfolio. As NPC initiated educational programs, and
its focus on evidence-based communications. Ms. Adams
More Than Half a Century of Expertise medicine and comparative works closely with the NPC
effectiveness, he developed President and the scientific
projects to establish a sound staff to ensure the smooth
1950s 1960s 1970s 1980s 1990s 2000s NPC NOW basis for this new focus. operation of research
Prior to joining NPC, Mr. activities and educational
National Pharmaceutical Council NPC launches annual pharmacy NPC develops “Compilation on State NPC works with states to As non-FDA-approved drugs remain a NPC sponsors first national symposium NPC hosts educational forums to NPC launches Managed Care Health NPC develops research papers focusing NPC turns focus to evidence-based Persinger served as Vice programs for public and
incorporates in New York City (1953) internship program with American Welfare Drug Programs,” which would examine open drug programs factor, NPC expands educational efforts on the issue of medication compliance, increase public awareness and Outcomes Project; findings suggest on the contribution of new drugs to medicine and comparative effectiveness President for Research and private payers and health
Pharmacists Association (1959) later become the annual “Pharmaceutical versus closed formularies; with consumer organizations, medical featuring then Surgeon General C. understanding of pharmaceuticals, the that closed formulary restrictions might improved health and reduced medical research issues; grows staff resources to Information Services at the care policymakers.
NPC focuses on educating states about Benefits Under State Medical Assistance electronic data processing and pharmacy students and their related Everett Koop; produces several major industry, and related issues; to assist have unintended consequences on the spending, and on the clinical needs of address new industry challenges (2007) Pharmaceutical Research and
the problem of unauthorized substitution Programs” (1963) systems developed through organizations, and federal agencies publications and develops widely viewed member companies in speaking about quality of health outcomes (1996) subpopulations Manufacturers of America.
of non-FDA-approved products at the this effort were later adapted public service announcement with the value of pharmaceuticals, produces NPC rapidly expands research portfolio,
pharmacy level NPC moves its headquarters to the by the federal government professional tennis player Arthur Ashe video, “Spread the Word,” that NPC hosts first annual member forum NPC launches educational project, Your partnerships, and communications
metropolitan Washington, DC area and acknowledged in the focusing on noncompliance receives a Telly Award for excellence in (1999) Pharmacy Benefit, to help consumers activities in the areas of evidence, value
(1965) publication, “Medicaid communications (1993) understand, choose and use the and innovation (2009)
Management Information pharmacy benefits under private
System” insurance and Medicare Part D (2006)
www.npcnow.org
 NPC Leadership

NPC leadership and staff bring a variety of experience from

within the biopharmaceutical industry, government health and
regulatory agencies, academia, and advocacy groups to our work.

Dan Leonard, Les D. Paul,

OUR APPROACH President, MD, MS, Vice
In shaping NPC’s research agenda and professional National Institute for Health and Clinical Excellence (NICE): variety of health care stakeholders, including patients, clinicians, leads NPC in President,
NPC is a policy research organization dedicated to the advancement of bringing the Clinical and
good evidence and science, and to fostering an environment in the United programming, we access the expertise of health outcomes How Does It Work and What Are the Implications for the U.S.?, payers and policy makers. biopharmaceu- Scientific
researchers, clinicians, market experts, and other industry The Current Evidence-Based Medicine Landscape, Principles tical industry’s Affairs, is
States that supports medical innovation. NPC educational events include:
leaders. The resulting research and educational events of Good Practice for Comparative Effectiveness Observational technical expertise and responsible for coordinating
demonstrate how the appropriate use of biopharmaceuticals Studies (GRACE), and Health Technology Assessment Town Hall Meetings – explore emerging issues of applied scientific knowledge NPC’s strategic focus
NPC focuses on research development, information dissemination, improves both patient treatment and cost outcomes in the Organizations in Other Countries and U.S. Implications. importance to the biopharmaceutical industry, such as value- to considerations of on evidence-based
based insurance design and evidence-based medicine, and evidence-based medicine, medicine (EBM) for health
education and promotion of the critical issues of evidence, innovation and overall health care environment. Value – As the United States looks for ways to ensure comparative effectiveness care decision making,
help member companies and other health care stakeholders
the value of medicines for patients. The issues we select for examination In carrying out our patient-centric mandate, NPC engages more value from medicines, NPC has undertaken several reviews, evaluation and helping to facilitate
better understand and translate research findings into everyday application. A veteran dialogue between the
and the researchers and academics we partner with position NPC as a with a targeted range of stakeholders, focusing on research studies examining this issue. The research we conduct and life; some are videotaped and made available to member association executive and biopharmaceutical industry
uniquely credible and trusted voice in the biopharmaceutical research and standards and methods for evidence generation, interpretation, commission is focused on enhancing understanding of the companies as educational tools; communications strategist and key stakeholders, and
health policy communities. and application that will improve patient outcomes while overall clinical and economic value of prescription medications with more than 20 years creating awareness and
sustaining and enhancing innovation and the value of and the contributions of those medications to improved health Corporate Roundtables – brief member companies and key of experience in strategic understanding of industry
biopharmaceuticals. and productivity among patients. Examples include recent stakeholders on industry issues, emerging trends, and related communications, legislative expertise and perspectives
NPC is working to: studies on Value-Based Insurance Design to raise awareness research; management, politics and on EBM. Dr. Paul also
For more than half a century, we have actively responded broadcast journalism, his provides clinical and
l Ensure that sound evidence is recognized by independent experts, and understanding of its value as health reform initiatives Forums/Symposiums – feature recognized health care and
to changes in the biopharmaceutical environment and previous health care industry scientific expertise for NPC’s
considered appropriately by private and public payers, reflected contributed to informative research in this arena. As we look to progress, and on Health and Productivity as a Business biopharmaceutical industry leaders; recent events include experience includes serving other research projects.
adequately in benefit designs, and incorporated into clinical practice; the future, NPC will continue to anticipate the issues, produce Strategy, which will contribute to understanding the full costs of NPC’s “Entering a New Era of Evidence,” and an NPC- as executive vice president of Dr. Paul, a Board Certified
health care for employers. sponsored symposium at ISPOR on mapping the current CER advocacy and professional pulmonologist and internist,
l Demonstrate and promote the contribution of innovative medicines to strong, evidence-based research and education, build new NPC-sponsored research publications are available online at services for America’s Health has more than 25 years of
optimizing health and wellness for patients and the entire health care partnerships, and demonstrate the benefits of new medicines Innovation – NPC believes strongly in the importance www.npcnow.org. landscape. Insurance Plans (AHIP). experience in health care.
system through scientific analyses and fact-based communications; to patients and to society. of fostering an environment that sustains and enhances NPC often works in partnership with other organizations Prior to joining NPC, his
innovation to ensure the continued discovery and Topical Educational Events – among them the Center for Medical Technology Policy Gary professional experience
l Maintain a focus on the issues related to advancing the science and Robust Research Agenda Focused on NPC’s professional programming advances the public dialogue Persinger, included senior medical
development of new medicines to improve patient health. This (CMTP), Pragmatic Approaches to Comparative Effectiveness
research aspects of the biopharmaceutical industry and preserving and Evidence, Value, Innovation by drawing on the biopharmaceutical industry’s science Vice President, affairs positions at Novartis
focus on innovation cuts across all streams of NPC-sponsored (PACE), and the Institute for Clinical and Economic Review Health Services Pharmaceutical Corporation,
improving an environment supportive of innovation. NPC’s research agenda has three core areas of focus: research. One recent study, for example, focused on how base and expertise as a resource for reducing uncertainty in
(ICER) – to contribute strategic and scientific input on critical Research, AstraZeneca, and Medco
evidence, value and innovation. pharmacogenomics may impact the future costs, risks and care decisions and improving outcomes for patients. Topical coordinates Health Solutions.
issues such as comparative effectiveness research. And NPC
returns on research and development, as well as incentives to educational events seek to introduce the industry’s perspective NPC’s research and
Evidence – Current efforts focus on Comparative Effectiveness researchers, members, and staff also play a prominent role
and expertise to inform the discussion and generate other activities related to Patricia L. Adams, Vice
Research (CER), including examining international models for invest in new research. on professional educational programs sponsored by other
momentum around key issues. NPC’s Annual Forum, held the value of medicines President, Business
possible lessons learned as the United States continues its organizations addressing key stakeholder issues, including the and the contribution of Operations and External
each fall in Washington, DC, offers a substantive program on
exploration into the development of a CER framework. Recent U.S. Chamber of Commerce, Health Industry Forum, and the innovation to value. He Affairs, is responsible for
issues of interest to the biopharmaceutical industry and a also provides expertise on the overall operations of
NPC research in this arena includes published reports on: Translational Medical Alliance.
research design and data NPC, including member
analysis for NPC’s research relations, external affairs,
portfolio. As NPC initiated educational programs, and
its focus on evidence-based communications. Ms. Adams
More Than Half a Century of Expertise medicine and comparative works closely with the NPC
effectiveness, he developed President and the scientific
projects to establish a sound staff to ensure the smooth
1950s 1960s 1970s 1980s 1990s 2000s NPC NOW basis for this new focus. operation of research
Prior to joining NPC, Mr. activities and educational
National Pharmaceutical Council NPC launches annual pharmacy NPC develops “Compilation on State NPC works with states to As non-FDA-approved drugs remain a NPC sponsors first national symposium NPC hosts educational forums to NPC launches Managed Care Health NPC develops research papers focusing NPC turns focus to evidence-based Persinger served as Vice programs for public and
incorporated in New York City (1953) internship program with American Welfare Drug Programs,” which would examine open drug programs factor, NPC expands educational efforts on the issue of medication compliance, increase public awareness and Outcomes Project; findings suggest on the contribution of new drugs to medicine and comparative effectiveness President for Research and private payers and health
Pharmacists Association (1959) later become the annual “Pharmaceutical versus closed formularies; with consumer organizations, medical featuring then Surgeon General C. understanding of pharmaceuticals, the that closed formulary restrictions might improved health and reduced medical research issues; grows staff resources to Information Services at the policymakers.
NPC focuses on educating states about Benefits Under State Medical Assistance electronic data processing and pharmacy students and their related Everett Koop; produces several major industry, and related issues; to assist have unintended consequences on the spending, and on the clinical needs of address new industry challenges (2007) Pharmaceutical Research and
the problem of unauthorized substitution Programs” (1963) systems developed through organizations, and federal agencies publications and develops widely viewed member companies in speaking about quality of health outcomes (1996) subpopulations Manufacturers of America.
of non-FDA-approved products at the this effort were later adapted public service announcement with the value of pharmaceuticals, produces NPC rapidly expands research portfolio,
pharmacy level NPC moves its headquarters to the by the federal government professional tennis player Arthur Ashe video, “Spread the Word,” that NPC hosts first annual member forum NPC launches educational project, Your partnerships, and communications
metropolitan Washington DC area and acknowledged in the focusing on noncompliance receives a Telly Award for excellence in (1999) Pharmacy Benefit, to help consumers activities in the areas of evidence, value
(1965) publication, “Medicaid communications (1993) understand, choose and use the and innovation (2009)
Management Information pharmacy benefits under private
System” insurance and Medicare Part D (2006)
www.npcnow.org
 NPC Leadership

NPC leadership and staff bring a variety of experience from

within the biopharmaceutical industry, government health and
regulatory agencies, academia, and advocacy groups to our work.

Dan Leonard, Les D. Paul,

OUR APPROACH President, MD, MS, Vice
In shaping NPC’s research agenda and professional National Institute for Health and Clinical Excellence (NICE): variety of health care stakeholders, including patients, clinicians, leads NPC in President,
NPC is a policy research organization dedicated to the advancement of bringing the Clinical and
good evidence and science, and to fostering an environment in the United programming, we access the expertise of health outcomes How Does It Work and What Are the Implications for the U.S.?, payers and policy makers. biopharmaceu- Scientific
researchers, clinicians, market experts, and other industry The Current Evidence-Based Medicine Landscape, Principles tical industry’s Affairs, is
States that supports medical innovation. NPC educational events include:
leaders. The resulting research and educational events of Good Practice for Comparative Effectiveness Observational technical expertise and responsible for coordinating
demonstrate how the appropriate use of biopharmaceuticals Studies (GRACE), and Health Technology Assessment Town Hall Meetings – explore emerging issues of applied scientific knowledge NPC’s strategic focus
NPC focuses on research development, information dissemination, improves both patient treatment and cost outcomes in the Organizations in Other Countries and U.S. Implications. importance to the biopharmaceutical industry, such as value- to considerations of on evidence-based
based insurance design and evidence-based medicine, and evidence-based medicine, medicine (EBM) for health
education and promotion of the critical issues of evidence, innovation and overall health care environment. Value – As the United States looks for ways to ensure comparative effectiveness care decision making,
help member companies and other health care stakeholders
the value of medicines for patients. The issues we select for examination In carrying out our patient-centric mandate, NPC engages more value from medicines, NPC has undertaken several reviews, evaluation and helping to facilitate
better understand and translate research findings into everyday application. A veteran dialogue between the
and the researchers and academics we partner with position NPC as a with a targeted range of stakeholders, focusing on research studies examining this issue. The research we conduct and life; some are videotaped and made available to member association executive and biopharmaceutical industry
uniquely credible and trusted voice in the biopharmaceutical research and standards and methods for evidence generation, interpretation, commission is focused on enhancing understanding of the companies as educational tools; communications strategist and key stakeholders, and
health policy communities. and application that will improve patient outcomes while overall clinical and economic value of prescription medications with more than 20 years creating awareness and
sustaining and enhancing innovation and the value of and the contributions of those medications to improved health Corporate Roundtables – brief member companies and key of experience in strategic understanding of industry
biopharmaceuticals. and productivity among patients. Examples include recent stakeholders on industry issues, emerging trends, and related communications, legislative expertise and perspectives
NPC is working to: studies on Value-Based Insurance Design to raise awareness research; management, politics and on EBM. Dr. Paul also
For more than half a century, we have actively responded broadcast journalism, his provides clinical and
l Ensure that sound evidence is recognized by independent experts, and understanding of its value as health reform initiatives Forums/Symposiums – feature recognized health care and
to changes in the biopharmaceutical environment and previous health care industry scientific expertise for NPC’s
considered appropriately by private and public payers, reflected contributed to informative research in this arena. As we look to progress, and on Health and Productivity as a Business biopharmaceutical industry leaders; recent events include experience includes serving other research projects.
adequately in benefit designs, and incorporated into clinical practice; the future, NPC will continue to anticipate the issues, produce Strategy, which will contribute to understanding the full costs of NPC’s “Entering a New Era of Evidence,” and an NPC- as executive vice president of Dr. Paul, a Board Certified
health care for employers. sponsored symposium at ISPOR on mapping the current CER advocacy and professional pulmonologist and internist,
l Demonstrate and promote the contribution of innovative medicines to strong, evidence-based research and education, build new NPC-sponsored research publications are available online at services for America’s Health has more than 25 years of
optimizing health and wellness for patients and the entire health care partnerships, and demonstrate the benefits of new medicines Innovation – NPC believes strongly in the importance www.npcnow.org. landscape. Insurance Plans (AHIP). experience in health care.
system through scientific analyses and fact-based communications; to patients and to society. of fostering an environment that sustains and enhances NPC often works in partnership with other organizations Prior to joining NPC, his
innovation to ensure the continued discovery and Topical Educational Events – among them the Center for Medical Technology Policy Gary professional experience
l Maintain a focus on the issues related to advancing the science and Robust Research Agenda Focused on NPC’s professional programming advances the public dialogue Persinger, included senior medical
development of new medicines to improve patient health. This (CMTP), Pragmatic Approaches to Comparative Effectiveness
research aspects of the biopharmaceutical industry and preserving and Evidence, Value, Innovation by drawing on the biopharmaceutical industry’s science Vice President, affairs positions at Novartis
focus on innovation cuts across all streams of NPC-sponsored (PACE) Initiative, and the Institute for Clinical and Economic Health Services Pharmaceutical Corporation,
improving an environment supportive of innovation. NPC’s research agenda has three core areas of focus: research. One recent study, for example, focused on how base and expertise as a resource for reducing uncertainty in
Review (ICER) – to contribute strategic and scientific input on Research, AstraZeneca, and Medco
evidence, value and innovation. pharmacogenomics may impact the future costs, risks and care decisions and improving outcomes for patients. Topical coordinates Health Solutions.
critical issues such as comparative effectiveness research. And
returns on research and development, as well as incentives to educational events seek to introduce the industry’s perspective NPC’s research and
Evidence – Current efforts focus on Comparative Effectiveness NPC researchers, members, and staff also play a prominent
and expertise to inform the discussion and generate other activities related to Patricia L. Adams, Vice
Research (CER), including examining international models for invest in new research. role on professional educational programs sponsored by other
momentum around key issues. NPC’s Annual Forum, held the value of medicines President, Business
possible lessons learned as the United States continues its organizations addressing key stakeholder issues, including the and the contribution of Operations and External
each fall in Washington, DC, offers a substantive program on
exploration into the development of a CER framework. Recent U.S. Chamber of Commerce, Health Industry Forum, and the innovation to value. He Affairs, is responsible for
issues of interest to the biopharmaceutical industry and a also provides expertise on the overall operations of
NPC research in this arena includes published reports on: Translational Medicine Alliance.
research design and data NPC, including member
analysis for NPC’s research relations, external affairs,
portfolio. As NPC initiated educational programs, and
its focus on evidence-based communications. Ms. Adams
More Than Half a Century of Expertise medicine and comparative works closely with the NPC
effectiveness, he developed President and the scientific
projects to establish a sound staff to ensure the smooth
1950s 1960s 1970s 1980s 1990s 2000s NPC NOW basis for this new focus. operation of research
Prior to joining NPC, Mr. activities and educational
National Pharmaceutical Council NPC launches annual pharmacy NPC develops “Compilation on State NPC works with states to As non-FDA-approved drugs remain a NPC sponsors first national symposium NPC hosts educational forums to NPC launches Managed Care Health NPC develops research papers focusing NPC turns focus to evidence-based Persinger served as Vice programs for public and
incorporated in New York City (1953) internship program with American Welfare Drug Programs,” which would examine open drug programs factor, NPC expands educational efforts on the issue of medication compliance, increase public awareness and Outcomes Project; findings suggest on the contribution of new drugs to medicine and comparative effectiveness President for Research and private payers and health
Pharmacists Association (1959) later become the annual “Pharmaceutical versus closed formularies; with consumer organizations, medical featuring then Surgeon General C. understanding of pharmaceuticals, the that closed formulary restrictions might improved health and reduced medical research issues; grows staff resources to Information Services at the care policymakers.
NPC focuses on educating states about Benefits Under State Medical Assistance electronic data processing and pharmacy students and their related Everett Koop; produces several major industry, and related issues; to assist have unintended consequences on the spending, and on the clinical needs of address new industry challenges (2007) Pharmaceutical Research and
the problem of unauthorized substitution Programs” (1963) systems developed through organizations, and federal agencies publications and develops widely viewed member companies in speaking about quality of health outcomes (1996) subpopulations Manufacturers of America.
of non-FDA-approved products at the this effort were later adapted public service announcement with the value of pharmaceuticals, produces NPC rapidly expands research portfolio,
pharmacy level NPC moves its headquarters to the by the federal government professional tennis player Arthur Ashe video, “Spread the Word,” that NPC hosts first annual member forum NPC launches educational project, Your partnerships, and communications
metropolitan Washington, DC area and acknowledged in the focusing on noncompliance receives a Telly Award for excellence in (1999) Pharmacy Benefit, to help consumers activities in the areas of evidence, value
(1965) publication, “Medicaid communications (1993) understand, choose and use the and innovation (2009)
Management Information pharmacy benefits under private
System” insurance and Medicare Part D (2006)
www.npcnow.org
NPC Leadership
NPC leadership and staff bring a variety of experience from within the biopharmaceutical
industry, government health and regulatory agencies, academia, and advocacy groups to
our work.
Dan Leonard,
President, leads NPC in
bringing the biopharmaceu-tical
industry’s technical expertise
and applied scientific knowledge
to considerations of evidence-
based medicine, comparative
effectiveness reviews, evaluation and
application. A veteran association executive and
communications strategist with more than 20
years of experience in strategic communications,
legislative management, politics and broadcast
journalism, his previous health care industry
experience includes serving as executive vice
president of advocacy and professional services
for America’s Health Insurance Plans (AHIP).
Gary Persinger,
Vice President, Health Services
Research, coordinates NPC’s
research and other activities
related to the value of medicines
and the contribution of
innovation to value. He also
provides expertise on research design and data
analysis for NPC’s research portfolio. As NPC
initiated its focus on evidence-based medicine
and comparative effectiveness, he developed
projects to establish a sound basis for this new
focus. Prior to joining NPC, Mr. Persinger served
as Vice President for Research and Information
Services at the Pharmaceutical Research and
Manufacturers of America.
1894 Preston White Drive | Reston, VA 20191-5433
www.npcnow.org
Les D. Paul, MD, MS,
Vice President, Clinical and
Scientific Affairs, is responsible for
coordinating NPC’s strategic focus on
evidence-based medicine (EBM) for
health care decision making, helping
to facilitate dialogue between the
biopharmaceutical industry and key stakeholders,
and creating awareness and understanding of
industry expertise and perspectives on EBM. Dr.
Paul also provides clinical and scientific expertise
for NPC’s other research projects. Dr. Paul, a Board
Certified pulmonologist and internist, has more than
25 years of experience in health care. Prior to joining
NPC, his professional experience included senior
medical affairs positions at Novartis Pharmaceuticals
Corporation, AstraZeneca, and Medco Health
Solutions.
Patricia L. Adams, Vice President, Business
Operations and External Affairs, is responsible for
the overall operations of NPC, including member
relations, external affairs, educational programs, and
communications. Ms. Adams works closely with
the NPC President and the scientific staff to ensure
the smooth operation of research activities and
educational programs for public and private payers
and health care policymakers.
 Additional resources online:

NPC MEMBERS
2 0 0 9 www.npcnow.org
contains a wealth of information
Abbott Laboratories
www.abbott.com about the biopharmaceutical
industry’s most pressing issues,
AstraZeneca LP
including a research and
www.astrazeneca-us.com
publications library and daily
Bayer HealthCare Pharmaceuticals news updates
pharma.bayer.com

Boehringer Ingelheim Pharmaceuticals, Inc.

www.boehringer-ingelheim.com
The National Pharmaceutical Council (NPC) is the credible and trusted voice of

ence
Bristol-Myers Squibb Company
the biopharmaceutical industry on the critical issues of evidence, the value of medicines for
www.bms.com
patients, and innovation. E.V.I.dently
Evidence. Value. Innovation

e
Daiichi Sankyo, Inc.
www.daiichisankyo-us.com

u
OUR MISSION

Evid
NPC’s monthly electronic

Val
Eisai Inc. newsletter focused on evidence-

on
www.eisai.com based medicine and related
NPC sponsors, participates in and promotes scientific analyses of the appropriate use of research relevant to the

ati
Eli Lilly and Company
www.lilly.com biopharmaceuticals, and the clinical and economic value of improved health outcomes biopharmaceutical industry
through innovation. NPC actively participates with a variety of health care stakeholders to

ov
Johnson & Johnson
www.jnj.com demonstrate and communicate the value of biopharmaceuticals and vaccines through

Inn
practical, evidence-based applications and tools.
Merck & Co., Inc.
www.merck.com
Novartis Pharmaceuticals Corporation NPC’s strategic focus is on evidence-based medicine (EBM) for health care decision making
www.novartis.com to ensure that patients have access to high quality care.
Pfizer Inc
www.pfizer.com

sanofi-aventis
www.sanofi-aventis.com

Schering-Plough Corporation
www.schering-plough.com

Takeda Pharmaceuticals
North America, Inc. 1894 Preston White Drive
www.tpna.com Reston, VA 20191-5433
Teva Neuroscience
www.tevaneuroscience.com Evidence-Based Medicine 1501 M Street, NW
Ensuring patients receive Suite 650
appropriate care based on Washington, DC 20005
individual needs and conditions
through decision making that uses Phone: 703.620.6390
the best available scientific and
Patients
1894 Preston White Drive | Reston, VA 20191-5433
Fax: 703.476.0904
www.npcnow.org clinical knowledge

www.npcnow.org

www.npcnow.org